The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol

The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol

Bibliographic Details
Main Author:	Dong-Ryeol Ryu
Format:	Article
Language:	English
Published:	The Korean Society of Nephrology 2017-09-01
Series:	Kidney Research and Clinical Practice
Online Access:	https://doi.org/10.23876/j.krcp.2017.36.3.207

Similar Items

Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
by: Andreas Jordan, et al.
Published: (2018-05-01)

Xanthine oxidase inhibition in SARS-CoV-2 infection: the mechanism and potency of allopurinol and febuxostat in COVID-19 management
by: Irandi Putra Pratomo, et al.
Published: (2020-11-01)

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
by: Sollip Kim, et al.
Published: (2017-09-01)

Febuxostat, a Xanthine Oxidase Inhibitor, Decreased Macrophage Matrix Metalloproteinase Expression in Hypoxia
by: Shuoyu Wei, et al.
Published: (2020-11-01)

The efficacy and safety of febuxostat versus allopurinol in gout patients with hyperuricemia
by: Jung-Yi Chen, et al.
Published: (2016)

Inhibition mechanism of baicalein and baicalin on xanthine oxidase and their synergistic effect with allopurinol
by: Ni Zeng, et al.
Published: (2018-11-01)

Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition
by: Yong Li, et al.
Published: (2016-06-01)

Xanthine Oxidase Inhibitor, Allopurinol, Prevented Oxidative Stress, Fibrosis, and Myocardial Damage in Isoproterenol Induced Aged Rats
by: Md. Abu Taher Sagor, et al.
Published: (2015-01-01)

Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice
by: Maimaiti Yisireyili, et al.
Published: (2017-04-01)

Comparison of Efficacy of Febuxostat with Allopurinol in Lowering Serum Urate Levels
by: Muhammad Osama Osama
Published: (2017-06-01)

Febuxostat, an inhibitor of xanthine oxidase, suppresses lipopolysaccharide-induced MCP-1 production via MAPK phosphatase-1-mediated inactivation of JNK.
by: Johji Nomura, et al.
Published: (2013-01-01)

Effects of Cherry in Take Versus Allopurinol on Serum Uric Acid Levels, Biomarkers of Oxidative Stress and Hepatic Xanthine Oxidase/Xanthine Dehydrogenase Activity in Hyperuricemic Rats
by: F Haidari
Published: (2012-05-01)

Effects of Cherry in Take Versus Allopurinol on Serum Uric Acid Levels, Biomarkers of Oxidative Stress and Hepatic Xanthine Oxidase/Xanthine Dehydrogenase Activity in Hyperuricemic Rats
by: F. Haidari, et al.
Published: (2008-07-01)

Effects of Cherry in Take Versus Allopurinol on Serum Uric Acid Levels, Biomarkers of Oxidative Stress and Hepatic Xanthine Oxidase/Xanthine Dehydrogenase Activity in Hyperuricemic Rats
by: F F Haidari, et al.
Published: (2008-06-01)

Studies on xanthine oxidase inhibitors
by: Xu, Xiu Yun, et al.
Published: (1996)

Xanthine Oxidase Inhibitor Febuxostat Exerts an Anti-Inflammatory Action and Protects against Diabetic Nephropathy Development in KK-Ay Obese Diabetic Mice
by: Yu Mizuno, et al.
Published: (2019-09-01)

African American patients with gout: efficacy and safety of febuxostat vs allopurinol
by: Wells Alvin F, et al.
Published: (2012-02-01)

Evaluation of analgesic activity of allopurinol and febuxostat in experimental analgesic models in mice
by: Promod D Shankpal, et al.
Published: (2015-01-01)

Xanthine oxidase inhibitors in asymptomatic hyperuricemia
by: O. V. Zhelyabina, et al.
Published: (2019-10-01)

Non purine inhibitors of xanthine oxidase
by: Leigh, Maria
Published: (2011)

Acute kidney injury associated with febuxostat and allopurinol: a post-marketing study
by: Amayelle Rey, et al.
Published: (2019-11-01)

Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis
by: Jasvinder A. Singh, et al.
Published: (2018-08-01)

Long-term inhibition of xanthine oxidase by febuxostat does not decrease blood pressure in deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
by: Theodora Szasz, et al.
Published: (2013-01-01)

Some opportunities of using xanthine oxidase inhibitors
by: O. V. Zhelyabina, et al.
Published: (2019-03-01)

A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout
by: Fengchun Zhang, et al.
Published: (2019-09-01)

Switching from allopurinol to febuxostat: efficacy and safety in the treatment of hyperuricemia in renal transplant recipients
by: Yanchun Li, et al.
Published: (2019-01-01)

The Xanthine Oxidase Inhibitor Febuxostat Suppresses the Progression of IgA Nephropathy, Possibly via Its Anti-Inflammatory and Anti-Fibrotic Effects in the gddY Mouse Model
by: Masa-Ki Inoue, et al.
Published: (2018-12-01)

Study of potential xanthine oxidase inhibitors: In silico and in vitro biological activity
by: Muthuswamy Umamaheswari, et al.
Published: (2011-12-01)

Studies on Xanthine Oxidase and Xanthine Dehydrogenase
by: Barber, M. J.
Published: (1976)

Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”
by: Kevin D. B. van Leeuwen, et al.
Published: (2019-12-01)

Comparative evaluation of uricodepressants allopurinol and febuxostat in gouty nephropathy. Message 1. Сlinical study
by: D.D. Ivanov, et al.
Published: (2018-04-01)

Comparative evaluation of uricodepressants allopurinol and febuxostat in gouty nephropathy. Message 2. Еxperimental study
by: O.V. Sinyachenko, et al.
Published: (2018-04-01)

Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis
by: Shengzhao Zhang, et al.
Published: (2021-06-01)

Structure–Activity Relationship of Xanthones as Inhibitors of Xanthine Oxidase
by: Ling-Yun Zhou, et al.
Published: (2018-02-01)

Inhibition of xanthine oxidase by allopurinol prevents skeletal muscle atrophy: role of p38 MAPKinase and E3 ubiquitin ligases.
by: Frederic Derbre, et al.
Published: (2012-01-01)

Xanthine oxidase in the lung
by: Wilson, Wendy Lee
Published: (2010)

The Influence Study of Allopurinol and Febuxostat in Thyroid Patient’s Treatment by Taiwanese National Health Insurance Research Database
by: PAI,YA-CHUN, et al.
Published: (2019)

Constructing Predictive Model of Febuxostat and Allopurinol therapeutic effect in patients with Cardiovascular disease、Renal and Liver dysfunction
by: Yun-Zun Huang, et al.
Published: (2016)

Exploring the therapeutic potential of xanthine oxidase inhibitor-AUopurinol, in stable coronary artery disease
by: Rajendra, N. S.
Published: (2010)

Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
by: Hirotaka Saito, et al.
Published: (2021-01-01)